Clinical Trials
22 trialsNCT00036790 2019-12-17
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
University of Wisconsin, Madison
Phase 1 Completed
NCT00003736 2019-09-24
MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT00006452 2018-06-27
Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00305864 2018-03-05
Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00003411 2016-01-18
Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer
University of Pittsburgh
Phase 1 Completed
NCT00003410 2013-06-26
Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas
National Cancer Institute (NCI)
Phase 1 Completed
NCT00022256 2013-06-18
Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00004262 2013-06-04
Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1 Completed
NCT00005065 2013-06-04
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003798 2012-11-14
Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00080054 2009-04-03
A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
Pharmacyclics LLC.
Phase 1 Completed
NCT00102505 2009-04-03
A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
Pharmacyclics LLC.
Phase 1 Completed
NCT00120939 2009-04-03
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer
Pharmacyclics LLC.
Phase 1 Completed
NCT00003409 2009-02-09
Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1 Completed
NCT00032097 2009-02-09
Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain
National Cancer Institute (NCI)
Phase 1 Completed
NCT00290004 2008-09-11
Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Pharmacyclics LLC.
Phase 1/2 Completed
NCT00129844 2008-08-20
Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer
Pharmacyclics LLC.
Phase 2 Completed
NCT00080041 2007-05-15
Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors
Pharmacyclics LLC.
Phase 1 Completed
NCT00086034 2007-05-15
Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
Pharmacyclics LLC.
Phase 2 Completed
NCT00054795 2007-05-08
Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)
Pharmacyclics LLC.
Phase 3 Completed
NCT00134186 2007-03-05
Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer
Pharmacyclics LLC.
Phase 2 Completed
NCT00096837 2006-06-08
A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
Pharmacyclics LLC.
Phase 2 Completed